West Palm Beach, FL, Mar 5, 2026 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), proudly announces the continued expansion of its Collegiate Partnership Program (CPP) for the 2026 season and academic year. Now in its eighth consecutive year, the program reaches a historic milestone by supporting 70 collegiate teams across 31 universities nationwide, the largest number of teams ever participating in the program.U.S. Polo Assn.'s Collegiate Partnership Program featuring the California Polytechnic State University Women's and Men's Polo TeamsPhoto Credit: California Polytechnic State University Polo TeamsU.S. Polo Assn. will outfit hundreds of student-athletes from coast to coast, including small private and large public institutions, Ivy League Universities, and Historically Black Colleges and Universities (HBCUs). The CPP supports 35 women's and 35 men's teams, reinforcing U.S. Polo Assn.'s long-standing commitment to growing the sport at the collegiate level. This season welcomes two new schools, Babson University and Southern Methodist University, joining a distinguished group of institutions nationwide.This year, U.S. Polo Assn. will generously provide each partnered program with custom-performance team jerseys, white performance game pants, polo shirts, caps, equipment gear bags, and exclusive USPA Pro merchandise, along with a monetary donation. The program also continues its popular collegiate social media contest, where teams have the opportunity to win additional prizes through creative digital engagement and storytelling.Participating Schools Include:Babson UniversityMorehouse CollegeTrinity UniversityUniversity of North TexasBrown UniversityOklahoma State UniversityUniversity of California - DavisUniversity of Southern CaliforniaCalifornia Polytechnic State UniversityOregon State UniversityUniversity of ConnecticutUniversity of South Carolina - AikenColorado State UniversitySkidmore CollegeUniversity of IdahoUniversity of VirginiaCornell UniversitySouthern Methodist UniversityUniversity of KentuckyUniversity of Wisconsin - MadisonGeorgetown UniversityStanford UniversityUniversity of MarylandVirginia Tech UniversityMichigan State UniversityTexas A&M UniversityUniversity of MichiganYale UniversityMontana State UniversityTexas Tech UniversityUniversity of New Hampshire "U.S. Polo Assn. is proud to support a record number of collegiate polo teams and student-athletes through the Collegiate Partnership Program," said J. Michael Prince, President and CEO of USPA Global, the company that manages the multi-billion-dollar U.S. Polo Assn. brand. "This critical program strengthens the foundation of the sport by providing meaningful resources to collegiate polo programs across the country. Supporting 70 teams this season reflects both the growth of the program and our long-term commitment to supporting the next generation of players both on and off the polo field."Enrollment for U.S. Polo Assn.'s Collegiate Partnership Program is open to all colleges and universities with a USPA-sanctioned polo team and lasts for the academic year. Collegiate polo teams compete in the Fall and Spring, with the official season running through April 2026 and culminating in the National Intercollegiate Championship (NIC)."Our partnership with U.S. Polo Assn. for the last eight years continues to make a meaningful difference for collegiate programs nationwide," said Liz Brayboy, Chair of the USPA's Intercollegiate/Interscholastic Committee. "The support provided through the Collegiate Partnership Program helps teams build stronger programs, develop student-athletes, and showcase the spirit and sportsmanship that define collegiate polo."The two-time award-winning series Breakaway, created by Global Polo, the media subsidiary of USPA Global, will feature a new episode in its upcoming season. Titled "Breakaway: Polo in College," the episode will air later this year on ESPNU, offering national exposure to the excitement and impact of collegiate polo. Check your local listings for air times.About U.S. Polo Assn. and USPA GlobalU.S. Polo Assn. is the official sports brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890 and located in Wellington, Florida. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,200 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. The brand sponsors major polo events around the world, including the U.S. Open Polo Championship®, held annually at NPC in The Palm Beaches, the premier polo tournament in the United States. Historic deals with ESPN in the United States, TNT and Eurosport in Europe, and Star Sports in India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, PGA Tour, and Formula 1, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global growth. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world. For more information, visit uspoloassnglobal.com and follow @uspoloassn.USPA Global is a subsidiary of the United States Polo Association (USPA) and manages the multi-billion-dollar sports brand, U.S. Polo Assn. USPA Global also manages the subsidiary, Global Polo, which is the worldwide leader in polo sport content. To learn more, visit globalpolo.com or Global Polo on YouTube.For Additional Information, Contact:Shannon Stilson - VP, Sports Marketing and MediaPhone +001.561.227.6994 - E-mail: sstilson@uspagl.comStacey Kovalsky - VP, Global PR and CommunicationsPhone +001.561.790.8036 - E-mail: skovalsky@uspagl.comSOURCE: U.S. Polo Assn. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - March 5, 2026) - Lancaster Resources Inc. (CSE: LCR) (OTC Pink: LANRF) (FSE: 6UF0) ("Lancaster" or the "Company") announces the director resignation of Penny White, effective March 3, 2026. The Board thanks Penny White for her valuable contributions during her tenure and wishes her continued success in her future endeavors.The Company is also pleased to announce the appointment of Mr. Rob Heaslop, as a director to the company's Board of Directors, effective immediately.Mr. Heaslop is a geologist with 20 years' of exploration and resource development experience in Africa, Australia, and the Pacific with specific expertise in project generation and early stage targeting for precious and base metal deposits. Mr. Heaslop holds a Bachelor of Science (Hons) from The University of Queensland majoring in earth science and geology, and during his career has worked for major, junior, and private exploration and mining companies. In 2016, Mr. Heaslop founded his privately owned project generation company, MRG Resources Pty Ltd, that has created significant value identifying exploration opportunities in Australia, including deals with major and mid-tier mining houses and private exploration companies. Mr. Heaslop is a member of the Australasian Institute of Mining and Metallurgy (MAusIMM), Australian Institute of Geoscientists (MAIG), and the Society of Economic Geologists (SEG)."We are thrilled to welcome Mr. Heaslop to the Board," said Andrew Watson, President & CEO of Lancaster Resources. "His technical expertise will be invaluable as Lancaster continues to develop our Lake Cargelligo gold project, Lac Iris polymetallic asset, and our other critical and precious mineral assets."Rob Heaslop commented, "I am focused on the opportunities ahead and committed to help navigate a successful exploration program for our projects and shareholders. I am truly excited to continue working with the team here."The new board appointment reflects Lancaster Resources' transition to a new corporate direction and commitment to strengthening its leadership and strategic capabilities to enhance shareholder value and propel the company's growth in the mining industry.Andrew Watson, P.Eng., President & CEO and a Director of the Company, is a Qualified Person as defined under National Instrument 43-101 – Standards of Disclosure for Mineral Projects. Mr. Watson has reviewed and approved the scientific and technical information contained in this news release. Mr. Watson is a Director and the President and CEO of Lancaster and is not independent of the Company.About Lancaster Resources Inc. Lancaster Resources Inc. is a Canadian exploration company advancing a diversified portfolio of gold and silver exploration projects in established mining jurisdictions. The Company holds a 100% interest in the Lake Cargelligo Gold Project in New South Wales, Australia, which is prospective for both gold and silver mineralization, covering approximately 62,300 hectares with a history of drilling and exploration and multiple high-priority targets. In Canada, Lancaster's assets include the Lac Iris Polymetallic Project in Quebec's James Bay region and the Piney Lake Gold Project in Saskatchewan. Lancaster's portfolio provides exposure to gold, silver, and polymetallic exploration opportunities across tier-one jurisdictions.Andrew Watson, President & Chief Executive Officer,Lancaster Resources Inc.Andrew@Lancaster-Resources.comTel: (604) 923-6100www.lancaster-resources.comThe Canadian Securities Exchange has not reviewed, approved nor disapproved the contents of this news release. Cautionary Statement Regarding Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking information. These statements relate to future events, or Lancaster's future performance. The use of any of the words "could", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on Lancaster's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, the ability of Lancaster to execute its exploration plans, raise capital, retain key personnel, identify, acquire, explore, and develop high-quality mineral-rich properties constitute forward-looking information. Actual results and developments may differ materially from those contemplated by forward-looking information. Readers are cautioned not to place undue reliance on forward-looking information. The statements made in this press release are made as of the date hereof. Lancaster disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as may be expressly required by applicable securities laws.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/286260 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SHENZHEN, CHINA, Mar 5, 2026 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that self-developed innovative drug INHBE-targeting small nucleic acid drug CMS-D008 injection (“CMS-D008”) received the Drug Clinical Trial Approval Notice issued by National Medical Products Administration (“NMPA”) on 4 March 2026. The NMPA has approved the conduct of clinical trials of CMS-D008 injection for overweight or obese individuals.About CMS-D008CMS-D008 is a novel siRNA therapy administered by subcutaneous injection. CMS-D008 targets and reduces the hepatic expression of the inhibin subunit beta E (INHBE) gene and lowers the level of Activin E protein encoded by INHBE, which blocks Activin E-ALK7 signaling and reduces fat accumulation effectively. Preclinical studies suggested that CMS-D008 efficiently and sustainably suppressed INHBE expression. In the diet-induced obesity model, CMS-D008 enhanced weight loss by reducing fat mass while retaining lean mass with a good safety profile. It demonstrates potentially better prospects for high-quality, long-term weight loss that boosts fat-specific loss while preserving muscle mass. In the future, it may be developed for the treatment of overweight/obesity, abdominal obesity, and related metabolic diseases.Fat Loss, muscle preserved: a potentially better therapeutic option for overweight/obesity Overweight or obesity is a chronic, progressive, relapsing disease characterized by excessive accumulation or abnormal distribution or function of body fat[1]. World Obesity Atlas 2025 Report projected that the global proportion of overweight and obese adults will rise to 50%, with nearly 3 billion adults impacted by high body mass index (BMI), and the population of adults who are overweight or obese in China is projected to reach 515 million by 2030[2]. Existing GLP-1RAs have been proven to be effective for the treatment of overweight and obesity. The main actions of GLP-1RAs are to suppress appetite by acting on the central nervous system and to delay gastric emptying[3]. INHBE’s novel mechanism of action differs from GLP-1RAs. INHBE is identified through genome-wide association studies. Populations with loss of function in INHBE are associated with favorable fat distribution and beneficial metabolic characteristics[4]. Targeted inhibition of INHBE might be more conducive for long-term weight management at the genetic level with precisely lower visceral fat and favorable metabolic profiles.CMS-D008 teams up with CMS-D005: highly effective weight loss plus long-term maintenance, building a more comprehensive weight-loss solutionCMS-D008 will synergize with CMS-D005, a self-developed innovative drug currently in clinical development. CMS-D008 reduces fat without sacrificing muscle mass by precisely inhibiting INHBE gene expression; while CMS-D005, as a GLP-1R/GCGR dual agonist, can effectively reduce liver fat while losing weight. The synergy between these two drugs will achieve highly effective weight loss benefits and long-term maintenance of results, jointly enhancing the Group’s R&D capabilities and product competitiveness in the field of obesity/metabolic treatment. Furthermore, leveraging the Group’s mature network resources in the field of cardiovascular and metabolic diseases, the drug’s R&D and commercialization process will be accelerated, providing patients with more comprehensive and innovative treatment options.The Group is actively preparing to initiate relevant clinical trials and strives to launch the Product as soon as possible.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.Reference:1. Chinese Society of Endocrinology. Guideline for chronic weight management and clinical practice of anti-obesity medications(2024 version). Chinese Journal of Endocrinology and Metabolism. 2024,40(7):545-564.2. World Obesity Federation. World Obesity Atlas 2025. London: World Obesity Federation, 2025. https://data.worldobesity.org/publications/?cat=233. Zhikai Zheng, Yao Zong, Yiyang Ma, Yucheng Tian, Yidan Pang, Changqing Zhang, Junjie Gao. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Sig Transduct Target Ther 9, 234 (2024). doi: 10.1038/s41392-024-01931-z4. Parsa Akbari, Olukayode A Sosina, Jonas Bovijn, et al. Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes. Nat Commun.2022 Aug 23;13(1):4844. doi: 10.1038/s41467-022-32398-7.CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, March 4, 2026 - (ACN Newswire via SeaPRwire.com) – The 42nd Hong Kong International Jewellery Show, organised by the Hong Kong Trade Development Council (HKTDC), opens today at the Hong Kong Convention and Exhibition Centre (HKCEC) and runs for five consecutive days until 8 March. It is held concurrently with the 12th Hong Kong International Diamond, Gem & Pearl Show which opened on Monday (2 March) at AsiaWorld-Expo and concludes on 6 March. The two shows bring together some 4,000 exhibitors from over 40 countries and regions, forming the world’s largest one-stop jewellery marketplace.Jenny Koo, Deputy Executive Director of the HKTDC, said: “Alongside the expanded Hall of Fame, the show will feature the debut of the Hard Pure Gold Pavilion and the Hong Kong Watch Manufacturers Association Pavilion. Furthermore, Uzbekistan is participating for the first time with a delegation of 10 companies, showcasing a wide range of gold jewellery. Through diversified exhibit profiles, we aim to create more collaboration opportunities for the industry and reinforce Hong Kong’s status as a global jewellery trading hub.”Kent Wong, Chairman of the Hong Kong International Jewellery Show and the Hong Kong International Diamond, Gem & Pearl Show Fair Organising Committee, said: “Hong Kong is an international trade and sourcing centre and our twin jewellery shows play a pivotal role. Continuing the successful ‘Two Shows, Two Venues’ format, the fairs attract global jewellery professionals for sourcing and networking, helping the industry capture the latest global market trends.”International brands converge, key zones expandAt the Hong Kong International Jewellery Show, the Hall of Fame has expanded by over 40%, welcoming more renowned international jewellery brands. Among them, Turkish exhibitor Hosgor Kuyumculuk Mucevherat Ticaret Limited Sirketi (Booth: CEC 3B-D15) presents a 35.5-carat diamond necklace that combines exquisite craftsmanship with brilliant radiance. Another highlight is the Hall of Extraordinary, which features exhibitors such as Hong Kong’s Glamour Fine Jewelry Enterprise Company (Booth: CEC GH-C16), showcasing a bracelet featuring Colombian emeralds paired with diamonds and rubies in a radiant and luxurious style.New pavilions highlight oriental aestheticsWith hard pure gold technologies gaining popularity in the Chinese Mainland, the Hard Pure Gold Pavilion (Booth: CEC 3E-F02) features 11 exhibitors organised by the World Gold Council. The pavilion showcases innovative techniques that produce harder, lighter and brighter gold pieces capable of setting a variety of gemstones. Also, the Hong Kong Watch Manufacturers Association Pavilion highlights crossover craftsmanship between jewellery setting and watchmaking.The fairs also feature several events celebrating oriental aesthetics. Today, the Jewellers’ and Goldsmiths’ Association of Hong Kong Limited presented the awards for the Hong Kong International Fashion Chuk Kam Jewellery Design Competition. The competition encourages designers to create culturally rich and commercially viable gold jewellery for the ASEAN and the Middle East markets. Tomorrow (5 March) will see the awards presentation of the inaugural International Fei Cui Jewellery Design Competition, organised by the Hong Kong Jade Association, honouring designers who skilfully blend jadeite with global cultural elements.Antique treasures and cutting-edge designAntique jewellery remains highly sought-after by collectors and high-end customers for its historical value and craftsmanship. The Antique & Vintage Jewellery Galleria presents an array of rare pieces, including a bi-colour enamel diamond piece from World Coins Co., Ltd. (Booth: CEC CH-N12), with a history spanning over a century. Design pieces are equally captivating, the Designer Galleria welcomes 10 Korean designers this year. Together with the Young Jewellery Designer Arena, participated by the Asia Pacific Creator Association and the Asia Jewelry Culture Design and Crafts Association, about 50 designer exhibitors will showcase their diverse creativities in the fairground.The HKTDC continues to nurture local talents in the jewellery industry. In partnership with the Jewellers’ and Goldsmiths’ Association of Hong Kong Limited, Hong Kong Jewellery & Jade Manufacturers Association, Hong Kong Jewelry Manufacturers’ Association, and Diamond Federation of Hong Kong, the 27th Hong Kong Jewellery Design Competition returns under the theme “Pure Elegance – Natural Beauty”, offering a stage for local professional designers and students. The awards ceremony will be held tomorrow (5 March) at the HKCEC, with winning pieces on display to demonstrate innovative design.E-commerce and technology empower industry growthTo help exhibitors expand into the Chinese Mainland market and develop their online sales channels, the fairs continue the collaboration with Taobao Tmall. For the first time, the fairs also welcome Douyin, partnering with influencers and KOLs for on-site live streaming to promote exhibitors’ products. On 7 March, a seminar will feature experts discussing the latest online marketing trends and tactics.Another seminar on 5 March will explore how AI and new technologies enhance competitiveness, optimise production, and drive product innovation in the jewellery industry.Engaging events to connect and inspireA diverse lineup of events will be held to foster industry dialogue. These include a seminar by Dr Jack Ogden, a distinguished British historian and jewellery authority, who will analyse the evolution of jewellery craftsmanship and changing aesthetic tastes throughout history. The jewellery parades will highlight themes such as intangible cultural heritage jewellery, curated selections from the Antique & Vintage Jewellery Galleria, as well as highlights from the Hall of Extraordinary, Designer Galleria, and gold jewellery.Full list of the winning entries from Hong Kong International Fashion Chuk Kam Jewellery Design Competition: https://bit.ly/46B5edLPhoto download: https://bit.ly/46GadtLThe 42nd Hong Kong International Jewellery Show opens today at the HKCEC, alongside the 12th Hong Kong International Diamond, Gem & Pearl Show at AWE, together gathering around 4,000 exhibitors from over 40 countries and regionsAnthony Lam, Chairman of the Federation of Hong Kong Industries (front row, centre); Bernard Chan, Under Secretary for Commerce and Economic Development (front row, fifth right); Sophia Chong, Executive Director of the HKTDC (front row, fifth left); Kent Wong, Chairman of the HKTDC twin jewellery shows’ Fair Organising Committee (front row, fourth right); Winston Chow, Chairman of the HKTDC Jewellery Advisory Committee (front row, fourth left), and other officiating guests attended today’s networking receptionThe Hall of Fame has expanded by over 40% this year, featuring more international brandsThe World Gold Council debuts the Hard Pure Gold Pavilion, featuring 11 exhibitors to showcase innovative hard pure gold craftsmanship to international buyersThe Hong Kong Watch Manufacturers Association Pavilion makes its first appearance, exhibiting luxury timepieces that integrate jewellery setting craftsmanshipShenzhen Meifei Precious Metals Co Ltd (Booth: CEC 3E-E02) presents 24K gold necklaces themed around oriental palatial and modern Chinese styles, employing six traditional gold techniquesHong Kong exhibitor Present Watch & Jewelry (Booth: CEC 1CON-019) showcases a diamond wristwatch inspired by the Northern Song masterpiece “Ode to the Lotus”, with a dial crafted to evoke a lotus pondTurkish brand Zen Diamond (Booth: CEC 3B-C12), which appointed global celebrity Jennifer Lopez as its ambassador in 2025, presents a series of diamond pieces at the showHong Kong designer Austy Lee (Booth: CEC 1EF32) launches a zebra-inspired-bangle for the Year of the HorseWinners of the Hong Kong International Fashion Chuk Kam Jewellery Design Competition pictured at the award ceremony with distinguished guestsFair detailsHong Kong International Jewellery ShowDateOpening hours4 March (Wednesday)10:30am to 6:30pm5-7 March (Thursday to Saturday)10am to 6:30pm8 March (Friday)10am to 5:30pmVenueHong Kong Convention and Exhibition Centre, 1 Expo Drive, Wan ChaiPress registration and Media CentreMedia representatives can register at the entrance of HKCEC Hall 1D Concourse, or at the HKTDC Media Centre (G/F, Expo Drive Entrance, HKCEC) by presenting a business card or media identification.* Hong Kong International Diamond, Gem & Pearl ShowDateOpening hours2 March (Monday)10:30am to 6:30pm3-5 March (Tuesday to Thursday)10am to 6:30pm6 March (Friday)10am to 5:30pmVenueAsiaWorld-Expo, Hong Kong International Airport, Lantau, Hong KongPress registration and Media CentreMedia representatives can register at the entrance of AsiaWorld-Expo’s East Lobby (Next to Hall 5) or at the Media Centre (Room 201C, 2/F) by presenting a business card or media identification.** For security reasons, all media will be required to present a name card and identity card (or passport) for press registration. Individuals with a valid press pass will be required to present their identity card (or passport) again at the entrance to the exhibition halls for identity verification. Please allow sufficient time for registration and admission.Websites Hong Kong International Jewellery ShowHong Kong International Diamond, Gem & Pearl ShowWebsitehttp://hkjewelleryshow.hktdc.comhttp://hkdgp.hktdc.comActivity listhttps://www.hktdc.com/event/hkjewellery/en/intelligence-hubhttps://www.hktdc.com/event/hkdgp/en/intelligence-hubShuttle bus arrangementshttps://www.hktdc.com/event/hkjewellery/en/travel-to-fairground-hkcechttps://www.hktdc.com/event/hkdgp/en/travel-to-fairground-aweHKTDC Media Room: https://mediaroom.hktdc.com/enMedia enquiriesPlease contact the HKTDC’s Communications & Public Affairs Department:Winnie KanTel: (852) 2584 4055Email: winnie.wy.kan@hktdc.orgKaty WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.orgJane CheungTel: (852) 2584 4137Email: jane.mh.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SINGAPORE, Mar 5, 2026 - (ACN Newswire via SeaPRwire.com) - Core Concepts Physio, one of Singapore's leading physiotherapy providers, has announced an expanded collaborative programme with podiatry service provider, Podiatry Quest, to offer enhanced, multidisciplinary assessments for patients experiencing plantar fasciitis and stubborn heel pain.Plantar fasciitis remains one of the most common and persistent causes of heel pain among adults, especially those with active lifestyles or occupations involving long hours on their feet. Often treatment seeks to address only one aspect of the condition rather than the full movement chain, which leads to recurring pain as other aspects remain unresolved.To bridge this gap, the two clinics have formalised a joint assessment pathway that evaluates plantar fasciitis from both the top-down (physiotherapy) and the bottom-up (podiatry) so as to ensure that no contributing factor is overlooked.A Smarter, More Complete Way to Diagnose Heel PainPhysiotherapy and podiatry traditionally manage different elements of plantar fasciitis. Physiotherapists focus on mobility, strength, gait and load tolerance, while podiatrists address foot posture, footwear, ground forces and orthotic support.The new integrated pathway combines both perspectives into a single, coordinated evaluation which results in:More accurate, holistic diagnosesFully optimised treatment strategiesFewer flare-ups and recurrencesClearer, consistent guidance for patientsFaster and more sustainable outcomes"Many patients struggle because plantar fasciitis isn't caused by just one issue," said Mr Chng Chye Tuan, Senior Principal Physiotherapist at Core Concepts Physiotherapy. "It's a movement chain problem involving the foot, calf, ankle mobility, daily load and footwear. When physiotherapists and podiatrists work together, we address every contributing factor — not just the symptoms."A Case Study Demonstrating Collaborative SuccessIn a recent case, a 42-year-old recreational runner sought help after six months of persistent heel pain. Physiotherapy improved his morning pain and running tolerance, but he continued to experience flare-ups following long work shifts.A podiatry assessment revealed prolonged pronation, footwear-related loading issues and inadequate shock absorption. With customised orthoses and tailored footwear recommendations, the patient's daily load decreased significantly — allowing physiotherapy progress to continue without setbacks.Within 10 weeks of coordinated care, he achieved pain-free mornings, comfortable workdays and full return to running."This case reflects what we see frequently," said Mr Yeo Boon Kiak, Principal Podiatrist at Podiatry Quest. "Physiotherapy builds tissue capacity, strength and movement control. Podiatry reduces unnecessary strain and optimises how forces enter the foot. When combined, this creates the ideal environment for long-lasting recovery."Making Multidisciplinary Care Accessible NationwideThrough this collaboration, patients with plantar fasciitis now benefit from:Joint physiotherapy–podiatry assessmentsAligned clinical decision-makingConsistent communication across providersA thorough evaluation of both the cause and consequence of heel painA fully optimised recovery pathway"Our multidisciplinary team brings together the best of both professions," said Mr Chng Chye Tuan. "Whether someone is a runner, a frequent traveller or stands long hours at work, this collaboration ensures their care is comprehensive, precise and built around their real-life demands."About Core Concepts PhysiotherapyCore Concepts Physio is one of Singapore's largest private physiotherapy groups, offering evidence-based musculoskeletal and sports physiotherapy across multiple clinic locations. Their multidisciplinary approach allows clients to benefit from integrated care, ensuring complete and effective recovery. Know more please contact marketing@coreconcepts.com.sg or call +65 62263632 or visit our office at 6 Raffles Quay, #11-01, Singapore 048580.About Podiatry QuestPodiatry Quest specialises in diagnosing and treating foot, ankle and lower limb conditions. Led by experienced podiatrists, the clinic offers services such as customised orthoses, biomechanical assessments, gait analysis and comprehensive podiatric care.Contact DetailsOrganization: Core Concepts Pte LtdContact: Clemence LimWebsite: https://www.coreconceptsphysio.sg Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Tashkent, Uzbekistan, Mar 5, 2026 - (ACN Newswire via SeaPRwire.com) -�FinHarbor, a modular financial infrastructure provider, has completed the core phase of a hybrid neobank platform for Asterium � a licensed fintech project in Uzbekistan that combines traditional banking with digital asset services under a single regulated framework.Why Uzbekistan - Uzbekistan is actively building a regulated environment for digital assets. The country has introduced a national distributed ledger system (Mirasmanda) and a state-backed digital asset (HUMO), supervised by the National Agency for Perspective Projects (NAPP). For infrastructure providers, this creates a rare opportunity: a market where crypto and banking can coexist within a clear legal perimeter.Asterium's project is designed to operate fully within this framework.What Was Deployed - FinHarbor adapted its microservices-based platform to the requirements of the Uzbek market and Asterium's business model. The core deployment covers three key layers:Banking infrastructure � management of fiat accounts, issuance of physical and virtual bank cards (VISA, MasterCard, HUMO), and integration with local processing systems.Digital asset infrastructure � crypto account management, integration with Bitcoin, Ethereum, and Tron networks, as well as native connection to Uzbekistan's Mirasmanda ledger for HUMO asset support.Compliance and exchange � a unified KYC/KYB/AML/KYT module aligned with local and international standards, integration with global AML/KYT providers, and multiple exchange models including fiat-to-crypto, crypto-to-fiat, and crypto-to-crypto conversions with card-based ramp-in and ramp-off.The result is a single platform where users can hold bank accounts and crypto wallets, exchange assets, and use cards � all within a regulated environment.How the Partnership Works - FinHarbor operates as Asterium's strategic technology partner, not just a software vendor. A dedicated implementation team supports the platform on an ongoing basis, managing feature rollouts and infrastructure expansion."This project required deep architectural customization � from integrating with a national blockchain system to building compliance workflows that satisfy both local regulators and international standards," said Ilya Podoynitsyn, CEO of FinHarbor. "The core phase is complete, and we are already scaling the platform with new products and business use cases."��What's Next - With the core infrastructure live, FinHarbor and Asterium are moving into the next stage: launching consumer-facing products and expanding the platform's functionality to support additional business lines built on the deployed stack.About FinHarborFinHarbor provides modular technology infrastructure for launching compliant financial products � from wallets and neobanks to crypto ramps and OTC desks. The platform supports fiat, crypto, and hybrid business models, with ISO/PCI DSS-certified architecture and deployment options across Europe, MENA, and CIS markets.Social LinksLinkedIn: https://www.linkedin.com/company/finharbor/Blog: https://www.finharbor.com/blog�Media contactBrand: FinHarborContact: Media teamWebsite: https://www.finharbor.com/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com